We’re on a mission to enable effective therapies to people faster.
A novel approach to research
For the past two decades clinical research has been hindered by outdated processes and technologies leaving millions without treatments.
After struggling to access patients in her own research in rare skin diseases, Dr. Michelle Longmire set out to solve this long-standing challenge in research.
Drawing inspiration from innovation and technological advancements in other industries, Longmire rallied stakeholders, partners, and developers to launch our company, Medable, with the shared vision of radically increasing the number of effective therapies to people each year.
Committed to science. Powered by innovation.
In order to achieve this vision, we needed to amplify the quality, reach, velocity, and cost of research.
Driven by the belief that clinical research can and should be better, we've assembled world-class scientific and product teams to continuously drive evidence-based improvements to the trial experience for all.
The relentless pursuit of progress, together.
Human connection is at the heart of everything we do. We prioritize the personal experience of patients, caregivers, knowing that their knowledge and feedback are essential to improving clinical research. In close partnership with with our network of sites, we continuously improve our platform, because we know that when they win, we all win. By designing products that are more accessible and user-friendly, we can bring life-change treatments to those who need them faster.
Together, with our clients and partners, we continue to work toward our mission and drive clinical research forward for the betterment of all.
Accolades
The latest from Medable
U.S. Renal Care achieves 75% site adoption of eConsent with Medable
Medable’s Total Consent, used by U.S. Renal Care in top ten pharma-sponsored study, proved to be a flexible, fast, and efficient solution for the elderly renal care population.
Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices
Industry experts from Medable and Harvard School of Medicine discuss how to equip your future digital/decentralized trial IRB & ethics submissions for success.
Rapid evolution: How DCT’s DNA became standard in modern clinical trials
It’s impossible to deny how different clinical trials look almost four years after the pandemic revolutionized clinical research. Today, the digital and decentralized tools and technologies that enabled clinical trials to carry on through the COVID-19 pandemic are present (in some form) in nearly all clinical trials, a far cry from the dynamics of 2019.
Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial
The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.
Medable Wins 2023 Prix Galien Award for Best Digital Health Solution
Medable was awarded ‘Best Digital Health Solution’ from a field of 24 nominees at the Prix Galien USA Forum in New York City. This recognition underscores the impact of Medable’s evidence generation platform on clinical research worldwide.
Medable Partners with Pluto Health to Optimize Patient Experience and Improve Access to Clinical Trials
This strategic partnership combines best-in-class patient care coordination service and clinical trialsplatform to streamline execution, improve data quality, and enhance patient experience.